TOI icon

The Oncology Institute

1.26 USD
+0.12
10.53%
At close Apr 1, 4:00 PM EDT
1 day
10.53%
5 days
-1.56%
1 month
74.03%
3 months
329.45%
6 months
293.14%
Year to date
329.45%
1 year
-19.23%
5 years
-87.01%
10 years
-87.01%
0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

7.8% less ownership

Funds ownership: 27.27% [Q3] → 19.47% (-7.8%) [Q4]

9% less funds holding

Funds holding: 34 [Q3] → 31 (-3) [Q4]

34% less capital invested

Capital invested by funds: $6.98M [Q3] → $4.61M (-$2.37M) [Q4]

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Research analyst outlook

We haven’t received any recent analyst ratings for TOI.

Financial journalist opinion

Based on 5 articles about TOI published over the past 30 days

Neutral
GlobeNewsWire
1 day ago
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1
CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida Oncology Network. This new fully delegated network will expand access to high-quality, coordinated cancer care for Florida residents.
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1
Neutral
Seeking Alpha
6 days ago
The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI ) Q4 2024 Earnings Conference Call March 25, 2025 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO Rob Carter - CFO Conference Call Participants Yuan Zhi - B. Riley Robert LeBoyer - NOBLE Capital Markets Operator Good afternoon, and welcome to The Oncology Institute's Fourth Quarter and Full-Year 2024 Earnings Conference Call.
The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
1 week ago
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025
CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2024.
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025
Neutral
GlobeNewsWire
1 week ago
The Oncology Institute Announces $16.5 million Private Placement
CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced it has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors for a private placement that is expected to result in gross proceeds of approximately $16.5 million, before deducting placement agent fees and offering expenses (the “Private Placement”). The Private Placement includes participation from existing investors, as well as members of the Company's management team and Board of Directors and is expected to close on March 26, 2025, subject to customary closing conditions.
The Oncology Institute Announces $16.5 million Private Placement
Neutral
GlobeNewsWire
4 weeks ago
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
CERRITOS, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its fourth quarter and full year 2024 financial results after the market close on Tuesday, March 25, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
Neutral
GlobeNewsWire
3 months ago
Florida Blue enhances cancer care for thousands of members
New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care
Florida Blue enhances cancer care for thousands of members
Neutral
GlobeNewsWire
4 months ago
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies
Proof that Digital Transformation and Smarter Supply Chains Can Massively Cut Costs Proof that Digital Transformation and Smarter Supply Chains Can Massively Cut Costs
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies
Neutral
Seeking Alpha
4 months ago
The Oncology Institute, Inc. (TOI) Q3 2024 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI ) Q3 2024 Earnings Conference Call November 13, 2024 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO Rob Carter - CFO Operator Good afternoon and welcome to The Oncology Institute's Third Quarter 2024 Earnings Conference Call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A.
The Oncology Institute, Inc. (TOI) Q3 2024 Earnings Call Transcript
Neutral
Accesswire
4 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology Institute, Inc.
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology Institute, Inc.
Neutral
Accesswire
4 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc.
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc.
Charts implemented using Lightweight Charts™